Market Cap ₹9237 Cr.
Stock P/E 49.8
P/B 3.1
Current Price ₹849.8
Book Value ₹ 272.7
Face Value 5
52W High ₹1297.4
Dividend Yield 0%
52W Low ₹ 849.2
Sheela Foam Ltd, formerly Sheela Foam Private Ltd, manufactures mattresses underneath Sleepwell logo. The Company manufactures other foam-based home comfort products focusing primarily at Indian retail consumers, in addition to technical grades of polyurethane (PU) foam for end use in various industries. Its home comfort line consists of products, inclusive of furniture-cushioning, cushions and sofa-cum-beds, as well as PU Foam cores utilized for manufacturing finished home comfort merchandise, and comfort add-ons, which includes bed sheets and toddler care sheets. Its mattress line, supplied below its Sleepwell range, consists of pure foam mattresses, in addition to hybrids of spring and coir with foam that are able to customization as in keeping with the necessities of purchasers. Its furniture-cushioning line, offered underneath Sleepwell and Feather Foam manufacturers, includes PU Foam that constitutes upholstery material of various densities. Through its subsidiary, it manufactures PU Foam in Australia.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 737 | 701 | 683 | 761 | 729 | 645 | 613 | 879 | 845 | 810 |
Other Income | 16 | 18 | 22 | 28 | 18 | 24 | 24 | 32 | 37 | 31 |
Total Income | 753 | 719 | 705 | 789 | 747 | 669 | 638 | 911 | 882 | 840 |
Total Expenditure | 665 | 635 | 604 | 685 | 651 | 567 | 547 | 803 | 765 | 750 |
Operating Profit | 88 | 84 | 100 | 104 | 96 | 102 | 91 | 108 | 117 | 90 |
Interest | 2 | 5 | 4 | 5 | 7 | 8 | 9 | 25 | 27 | 28 |
Depreciation | 24 | 21 | 21 | 22 | 26 | 23 | 22 | 30 | 41 | 40 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -11 | 0 | 0 | 34 | 31 |
Profit Before Tax | 62 | 58 | 75 | 77 | 63 | 60 | 60 | 53 | 83 | 53 |
Provision for Tax | 12 | 16 | 22 | 15 | 19 | 17 | 16 | 14 | 14 | 7 |
Profit After Tax | 49 | 43 | 54 | 61 | 44 | 43 | 45 | 38 | 68 | 47 |
Adjustments | -0 | -0 | -0 | -1 | -0 | -0 | -1 | -8 | -4 | -1 |
Profit After Adjustments | 49 | 42 | 53 | 61 | 43 | 43 | 44 | 31 | 65 | 46 |
Adjusted Earnings Per Share | 5 | 4.3 | 5.4 | 6.2 | 4.4 | 4.4 | 4 | 2.8 | 5.9 | 4.2 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1271 | 1418 | 1550 | 1733 | 1965 | 2141 | 2174 | 2437 | 2866 | 2873 | 2982 | 3147 |
Other Income | 8 | 11 | 17 | 23 | 21 | 29 | 40 | 50 | 79 | 86 | 117 | 124 |
Total Income | 1280 | 1429 | 1567 | 1756 | 1986 | 2171 | 2214 | 2487 | 2945 | 2959 | 3099 | 3271 |
Total Expenditure | 1194 | 1327 | 1374 | 1537 | 1749 | 1932 | 1873 | 2073 | 2551 | 2575 | 2682 | 2865 |
Operating Profit | 85 | 102 | 193 | 219 | 237 | 239 | 340 | 414 | 394 | 384 | 418 | 406 |
Interest | 19 | 16 | 12 | 11 | 9 | 10 | 13 | 18 | 17 | 21 | 69 | 89 |
Depreciation | 30 | 28 | 29 | 30 | 35 | 40 | 59 | 73 | 81 | 90 | 116 | 133 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -12 | 0 | 0 | 0 | 23 | 65 |
Profit Before Tax | 36 | 58 | 152 | 178 | 193 | 189 | 256 | 324 | 296 | 273 | 256 | 249 |
Provision for Tax | 8 | 15 | 47 | 52 | 60 | 56 | 62 | 84 | 78 | 72 | 61 | 51 |
Profit After Tax | 28 | 43 | 105 | 126 | 134 | 134 | 194 | 240 | 219 | 201 | 195 | 198 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -2 | -12 | -14 |
Profit After Adjustments | 28 | 43 | 105 | 126 | 134 | 134 | 193 | 238 | 217 | 199 | 182 | 186 |
Adjusted Earnings Per Share | 2.9 | 4.4 | 10.7 | 12.9 | 13.7 | 13.7 | 19.8 | 24.4 | 22.3 | 20.4 | 16.8 | 16.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 4% | 7% | 7% | 9% |
Operating Profit CAGR | 9% | 0% | 12% | 17% |
PAT CAGR | -3% | -7% | 8% | 21% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -21% | -11% | 6% | NA% |
ROE Average | 9% | 13% | 17% | 21% |
ROCE Average | 10% | 15% | 20% | 25% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 197 | 245 | 338 | 464 | 597 | 730 | 920 | 1184 | 1393 | 1598 | 2920 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 8 | 8 | 61 |
Borrowings | 87 | 73 | 35 | 22 | 8 | 6 | 157 | 133 | 228 | 284 | 945 |
Other Non-Current Liabilities | 32 | 40 | 47 | 53 | 72 | 84 | 176 | 417 | 438 | 264 | 276 |
Total Current Liabilities | 310 | 322 | 368 | 380 | 365 | 342 | 385 | 855 | 550 | 682 | 1129 |
Total Liabilities | 625 | 679 | 788 | 918 | 1043 | 1162 | 1644 | 2598 | 2616 | 2837 | 5331 |
Fixed Assets | 252 | 286 | 288 | 317 | 347 | 348 | 792 | 835 | 827 | 812 | 3078 |
Other Non-Current Assets | 25 | 21 | 36 | 55 | 103 | 128 | 95 | 646 | 1003 | 592 | 1378 |
Total Current Assets | 348 | 373 | 465 | 546 | 592 | 686 | 757 | 1116 | 786 | 1433 | 875 |
Total Assets | 625 | 679 | 788 | 918 | 1043 | 1162 | 1644 | 2598 | 2616 | 2837 | 5331 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 32 | 77 | 117 | 61 | 118 | 152 | 17 | 44 | 57 | 41 | 42 |
Cash Flow from Operating Activities | 124 | 147 | 159 | 122 | 134 | 138 | 157 | 254 | 197 | 218 | 406 |
Cash Flow from Investing Activities | -27 | -49 | -34 | 2 | -80 | -246 | -287 | -208 | -306 | -274 | -2258 |
Cash Flow from Financing Activities | -53 | -59 | -25 | -67 | -20 | -27 | 157 | -32 | 93 | 56 | 1854 |
Net Cash Inflow / Outflow | 45 | 40 | 100 | 57 | 34 | -135 | 27 | 13 | -17 | -0 | 2 |
Closing Cash & Cash Equivalent | 77 | 117 | 217 | 118 | 152 | 17 | 44 | 57 | 41 | 42 | 44 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 2.85 | 4.37 | 10.73 | 12.87 | 13.7 | 13.71 | 19.83 | 24.37 | 22.28 | 20.39 | 16.78 |
CEPS(Rs) | 5.93 | 7.24 | 13.73 | 15.98 | 17.32 | 17.76 | 25.97 | 32.08 | 30.7 | 29.77 | 28.55 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 20.15 | 25.12 | 34.69 | 47.52 | 61.22 | 74.83 | 94.27 | 121.38 | 142.73 | 163.82 | 268.42 |
Core EBITDA Margin(%) | 5.5 | 5.81 | 10.37 | 10.35 | 10.79 | 9.78 | 13.82 | 14.56 | 10.38 | 9.68 | 9.13 |
EBIT Margin(%) | 3.96 | 4.75 | 9.64 | 9.97 | 10.09 | 9.3 | 12.39 | 13.65 | 10.32 | 9.55 | 9.86 |
Pre Tax Margin(%) | 2.59 | 3.7 | 8.96 | 9.39 | 9.65 | 8.85 | 11.79 | 12.95 | 9.76 | 8.86 | 7.78 |
PAT Margin (%) | 1.99 | 2.75 | 6.17 | 6.63 | 6.67 | 6.25 | 8.94 | 9.6 | 7.21 | 6.52 | 5.91 |
Cash Profit Margin (%) | 4.14 | 4.55 | 7.9 | 8.23 | 8.43 | 8.09 | 11.65 | 12.51 | 9.87 | 9.43 | 9.43 |
ROA(%) | 4.67 | 6.54 | 14.27 | 14.71 | 13.64 | 12.13 | 13.85 | 11.32 | 8.39 | 7.37 | 4.76 |
ROE(%) | 15.21 | 19.33 | 35.89 | 31.31 | 25.21 | 20.15 | 23.55 | 22.83 | 16.98 | 13.43 | 8.61 |
ROCE(%) | 14.39 | 19.02 | 38.75 | 38.68 | 34.61 | 28.32 | 28.47 | 27.09 | 20.08 | 15.5 | 10.36 |
Receivable days | 29.34 | 27.56 | 24.92 | 24.65 | 26.05 | 25.52 | 30.89 | 37.79 | 34.36 | 32.66 | 35.81 |
Inventory Days | 31.41 | 28.47 | 23.97 | 24.19 | 29.05 | 30.66 | 34.76 | 39.56 | 37.86 | 38.25 | 37.19 |
Payable days | 44.48 | 46.9 | 52.81 | 54.77 | 53.63 | 46.33 | 52.83 | 66.96 | 62.36 | 58.11 | 69.55 |
PER(x) | 0 | 0 | 0 | 43.73 | 54.52 | 45.9 | 32.74 | 40.55 | 78.02 | 48.82 | 56.03 |
Price/Book(x) | 0 | 0 | 0 | 11.84 | 12.21 | 8.41 | 6.89 | 8.14 | 12.18 | 6.08 | 3.5 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.1 | 0.03 | -0.06 | 3.08 | 3.65 | 2.87 | 2.99 | 4.02 | 6.02 | 3.53 | 3.84 |
EV/Core EBITDA(x) | 1.49 | 0.44 | -0.44 | 24.36 | 30.24 | 25.77 | 19.1 | 23.62 | 43.78 | 26.42 | 27.43 |
Net Sales Growth(%) | 10.62 | 11.53 | 9.33 | 11.8 | 13.42 | 8.96 | 1.5 | 12.13 | 17.58 | 0.27 | 3.79 |
EBIT Growth(%) | -11.88 | 33.29 | 121.94 | 15.45 | 7.04 | -1.54 | 35.32 | 26.79 | -8.26 | -6.12 | 10.33 |
PAT Growth(%) | -9.76 | 53.28 | 145.38 | 19.9 | 6.49 | 0.02 | 45.27 | 23.61 | -8.92 | -8.18 | -3.15 |
EPS Growth(%) | -9.76 | 53.28 | 145.39 | 19.9 | 6.49 | 0.03 | 44.63 | 22.9 | -8.58 | -8.46 | -17.69 |
Debt/Equity(x) | 0.96 | 0.59 | 0.34 | 0.13 | 0.08 | 0.04 | 0.23 | 0.17 | 0.24 | 0.29 | 0.44 |
Current Ratio(x) | 1.12 | 1.16 | 1.26 | 1.44 | 1.62 | 2 | 1.97 | 1.31 | 1.43 | 2.1 | 0.78 |
Quick Ratio(x) | 0.72 | 0.79 | 0.98 | 1.05 | 1.15 | 1.46 | 1.38 | 0.94 | 0.86 | 1.62 | 0.47 |
Interest Cover(x) | 2.89 | 4.55 | 14.02 | 17.22 | 23.32 | 20.68 | 20.73 | 19.31 | 18.46 | 13.96 | 4.73 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0.03 | 0.02 | 0.02 | 0.05 | 0.13 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 72.95 | 72.95 | 72.95 | 72.95 | 72.95 | 65.48 | 65.48 | 65.48 | 65.48 | 65.48 |
FII | 3.11 | 3.16 | 3.19 | 3.26 | 3.21 | 6.04 | 6.12 | 6.32 | 6.4 | 6.59 |
DII | 22.85 | 22.74 | 22.43 | 22.29 | 21.95 | 25.08 | 24.99 | 24.53 | 23.4 | 22.3 |
Public | 1.1 | 1.15 | 1.43 | 1.5 | 1.89 | 3.4 | 3.4 | 3.67 | 4.72 | 5.63 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 3.56 | 3.56 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 |
FII | 0.15 | 0.15 | 0.31 | 0.32 | 0.31 | 0.66 | 0.67 | 0.69 | 0.7 | 0.72 |
DII | 1.11 | 1.11 | 2.19 | 2.17 | 2.14 | 2.73 | 2.72 | 2.67 | 2.54 | 2.42 |
Public | 0.05 | 0.06 | 0.14 | 0.15 | 0.18 | 0.37 | 0.37 | 0.4 | 0.51 | 0.61 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4.88 | 4.88 | 9.76 | 9.76 | 9.76 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About